Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMAD3 divergent transcript (SMAD3-DT)
- Target
- SMAD3-DT
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
SMAD3 divergent transcript (SMAD3-DT) is a long non-coding RNA that is transcribed in the vicinity of the SMAD3 gene, often in the opposite (divergent) direction. Like many lncRNAs, SMAD3-DT is not translated into a protein, and its precise biological roles remain uncertain. Divergent transcripts often participate in regulating the expression of their overlapping or neighboring genes by mechanisms that may include chromatin remodeling, RNA-RNA interactions, or recruitment of transcriptional complexes. There is currently no evidence that SMAD3-DT acts as a therapeutic target, nor is it directly implicated in disease or drug action in any major clinical or pharmacological database.
- Other names
- SMAD3DTLINC00323
02
Biological functions
Not definitively established; likely involved in gene regulation as with many divergent transcripts, possibly epigenetic or transcriptional regulation
03
Disease associations
Other (unknown or not well established; lncRNAs can play regulatory roles in cancer, development, and other processes, but specific disease associations for SMAD3-DT are not documented in major databases as of now)
Beyond the preview
Go deeper on SMAD3 divergent transcript (SMAD3-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SMAD3 divergent transcript (SMAD3-DT).